WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 672
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 1042

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 11'296  10'838  10'381  9'941  9'521  6'653  5'764  4'702 
Births 406  396  385  374  363  281  266  228 
Surviving infants 375  364  353  342  331  251  229  190 
Pop. less than 5 years 1'785  1'726  1'664  1'602  1'547  1'174  1'052  849 
Pop. less than 15 years 4'758  4'594  4'425  4'258  4'108  2'974  2'549  2'092 
Female 15-49 years 2'687  2'567  2'449  2'336  2'226  1'501  1'322  1'080 

Number of reported case

(Click for retrospective incidence data for South Sudan)
Diphtheria
Japanese encephalitis
Measles 525  1'952  1'256 
Mumps
Pertussis
Polio*
Rubella 20 
Rubella (CRS)
Tetanus (neonatal) 25  48  45 
Tetanus (total) 32 
Yellow fever 128 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for South Sudan)
Vaccine year result method % card seen                                                
BCG 2011  75  EPI   51  64  73  57  61  50 
DTP1 2011  79  EPI   51  60  70  58  58  50 
DTP3 2011  55  EPI   51  56  68  46  43  50 
HepB_BD         
HepB3         
Hib3         
JapEnc         
MCV 2011  62  EPI   51  55  70  64  64  50 
MCV2         
PCV1         
PCV3         
Pol3 2011  59  EPI   51  56  68  46  43  50 
Rota1         
Rota_last         
Rubella1         
TT2plus 2011  65  EPI   51  41  50  61 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for South Sudan)
BCG 52  62  75 
DTP1 57  71  79 
DTP3 45  59  61 
HepB3
HepB_BD
Hib3
MCV 30  52  62 
MCV2
PAB 64  64  64 
PCV3
Pol3 50  64  66 
Rota_last

Number of districts in the country 80  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
88 
   
/
|
|
\
Greater or equal to 90% 16
From 80 to 89% 6
From 50 to 79% 34
Less than 50% 44
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 6, 10, 14 weeks; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes From January 2014
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
TT First contact; +1, +6 months; +1, +1 year; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes         
What years does the MYP cover? number 2012-2016  2012- 2016  2012 to 2016         
Nº of districts with microplans that include activities to raise immunization coverage number 80  80  79         

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  No  No         

System performance

Total Nº districts in country number 80  80  79         
Nº districts with DTP3 coverage >=80% number 18  33  36         
% of districts with DTP3 coverage >=80% From 0 to 100% 23  41  46         
Nº districts with measles (MCV1) coverage >=95% number 27  36  45         
% of districts with MCV1 coverage >=95% From 0 to 100% 34  45  57         

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No         
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR No  No  No         

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100%          

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.